Maintenance treatment in patients with locally advanced/metastatic urothelial carcinoma research hub

TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma: A single-arm Phase 2 trial

This study looks at two drugs, talazoparib and avelumab, for people with advanced bladder cancer that has responded to initial chemotherapy. It's a Phase 2 trial, meaning researchers are testing if this combination can help keep the cancer from growing back for longer.